FDA “Material Time, Material Extent” May Be Cloudy For Sunscreens
This article was originally published in The Rose Sheet
Executive Summary
Interim marketing for OTC drugs or "conditions" in the U.S. subject to a final or new monograph is barred under FDA's final rule on "material time, material extent" criteria
You may also be interested in...
FDA To Review Piroctone Olamine For OTC Dandruff Monograph Status
FDA is seeking safety and efficacy data on piroctone olamine for use as a single active ingredient in dandruff control products, the agency announced in a Federal Register 1notice Feb. 18
FDA To Review Piroctone Olamine For OTC Dandruff Monograph Status
FDA is seeking safety and efficacy data on piroctone olamine for use as a single active ingredient in dandruff control products, the agency announced in a Federal Register 1notice Feb. 18
Octyl Triazone Sales Of 400 Mil. Sunscreen Units Abroad Cited By FDA
Based on bulk material sales, nearly 400 mil. sunscreen dosage units containing octyl triazone have been sold in 35 countries, FDA notes in an evaluation of BASF's time and extent application for including the ingredient in the OTC sunscreen monograph